| Literature DB >> 29576241 |
Tiziano Marzo1, Damiano Cirri2, Lorenzo Ciofi2, Chiara Gabbiani3, Alessandro Feis4, Nancy Di Pasquale3, Matteo Stefanini5, Tarita Biver6, Luigi Messori7.
Abstract
The triplatinum complex of the 2,4,6-Tris(2-pyrimidyl)-1,3,5-triazine ligand, Pt3TPymT hereafter, has been prepared and characterized for the first time. NMR studies point out that the three platinum(II) centers possess an identical coordination environment. The interactions of Pt3TPymT with DNA were explored in comparison to the free ligand. Specifically, fluorescence, mass spectrometry, viscometry and melting measurements were carried out. In contrast to expectations, the obtained data reveal that no intercalative binding takes place; we propose that binding of Pt3TPymT to DNA mainly occurs through external/groove binding.Entities:
Keywords: Anticancer drug; Coordination chemistry; DNA; Platinum; TPymT
Mesh:
Substances:
Year: 2018 PMID: 29576241 DOI: 10.1016/j.jinorgbio.2018.03.009
Source DB: PubMed Journal: J Inorg Biochem ISSN: 0162-0134 Impact factor: 4.155